Kirsten Harting
Chief Tech/Sci/R&D Officer presso ALZINOVA AB
Profilo
Kirsten Harting is currently the Chief Medical Officer at Alzinova AB, SynAct Pharma AB, Tetra Pharm Technologies ApS, and Sandoz Group AG.
She previously worked as the Senior Director-Medical at CytoKi Pharma.
ApS.
Dr. Harting holds an MBA from Copenhagen Business School and a doctorate from the University of Copenhagen.
Posizioni attive di Kirsten Harting
| Società | Posizione | Inizio |
|---|---|---|
| ALZINOVA AB | Chief Tech/Sci/R&D Officer | 14/08/2023 |
| SANDOZ GROUP AG | Chief Tech/Sci/R&D Officer | - |
| SYNACT PHARMA AB | Chief Tech/Sci/R&D Officer | 15/02/2024 |
Tetra Pharm Technologies ApS
 Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Kirsten Harting
| Società | Posizione | Fine |
|---|---|---|
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Chief Tech/Sci/R&D Officer | - |
Formazione di Kirsten Harting
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SYNACT PHARMA AB | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| ALZINOVA AB | Health Technology |
| Aziende private | 2 |
|---|---|
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Commercial Services |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Health Technology |
- Borsa valori
- Insiders
- Kirsten Harting
